Language
According to a new study, among children and adolescents who received CD19 chimeric antigen receptor (CAR) T cell (CAR-T) injections, the infection rate increased in the first month after treatment and then decreased...
2020-10-07
When used in mice with human glioblastoma, CAR-T cell therapy targeting CD133 appears to be successful because it reduces the tumor burden in these mice and increases them...
2020-10-07In a recent preliminary study conducted in China, 7 COVID-19 patients received intravenous injections of donor mesenchymal stem cells (MSCs)-pluripotent cells, which are believed to have immunomodulatory effects, as a result of this intervention Show...
2020-10-07Drug resistance has always been the main challenge we face in the fight between humans and cancer. In the latest research report published in the international journal Nature Communications, scientists at the University of California and other instit...
2020-09-30CAR-T cells can not only extend the survival period of cancer patients, but also improve the quality of life after treatment...
2020-09-30Yvonne Chen, associate professor at the University of California, Los Angeles and member of the Johnson Comprehensive Cancer Center, genetically modified immune cells such as T cells to attack the most evasive enemy: cancer...
2020-09-30Most cancer patients, such as multiple myeloma, will relapse after treatment. This harsh reality has led scientists to seek new cancer cell targeting mechanisms to improve the depth and tolerance of multiple myeloma treatments...
2020-09-30Tumors create an unfavorable environment for immune cells (such as T cells) that fight cancer...
2020-09-30According to the latest data released by researchers at the Abramson Cancer Center of the University of Pennsylvania, CAR-T cells that have undergone Crispr-Cas9 gene editing can persist in cancer patients for several months, and can stably prolifera...
2020-09-30In a new study, researchers from the University of Pennsylvania and Stanford University combined two state-of-the-art methods-CRISPR (DNA editing) and T cell therapy (using immune system sentinels to destroy tumors)...
2020-09-30X-chain chronic granulomatous disease (X-chain chronic granulomatous disease, X-CGD) is a rare inherited blood disease...
2020-09-30Clarifying death receptor signaling is essential for CAR-T cell therapy\\nScientists have found ways to enhance CAR-T cell therapy...
2020-09-30Demystifying the key role of stem cells in lethal gastric cancer...
2020-09-30Genetically modified T cells (CAR-T) expressing chimeric antigen receptor (CAR) have been clinically successful in adoptive T cell therapy in B cell malignancies...
2020-09-30The clinical application of transgenic T cells (CAR-T cells) expressing chimeric antigen receptors (CAR) in the treatment of B-cell malignancies has been successful, but cytokine release syndrome (CRS) prevents this situation...
2020-09-30Neural progenitor cells (NPC) are a potential treatment for repairing and regenerating neurons after spinal cord injury. However, after NPC is transplanted into rodents, the harmful microenvironment of the damaged spinal cord leads to limited recover...
2020-09-30